|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07H 21/04 | (2006.01) |
| C12N 7/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 39/12 | (2006.01) | ||
| A61K 39/42 | (2006.01) |
| (11) | Number of the document | 2589602 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12182319.9 |
| Date of filing the European patent application | 2007-08-15 | |
| (97) | Date of publication of the European application | 2013-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (30) | Number | Date | Country code |
| 837723 P | 2006-08-15 | US |
| (72) |
Whitehead, Stephen S., US
Blaney, Joseph E., US
Murphy, Brian R., US
Ching-Juh Lai, US
|
| (73) |
The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health,
Office of Technology Transfer, Suite 325, 6011 Executive Blvd., Rockville, MD 20852-3804,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Dengė viruso vakcinos komponentų gavimas |
| Development of dengue virus vaccine components |
| Payment date | Validity (years) | Amount | |
| 2025-07-21 | 19 | 347.00 EUR |
| 2026-08-15 |